Thomas M. Gress

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Medicine, Oncology, Pharmacotherapy +17

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

Maik Luu, Zeno Riester, Adrian Baldrich et al. · Nature Communications · 2021 · 688 citations · Full text

Life Sciences, Immunology, Oncology +17

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Michael Goggins, Kasper A. Overbeek, Randall E. Brand et al. · Gut · 2019 · 625 citations · Full text

Medicine, Genetics, Oncology +17

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

Phil A. Hart, Terumi Kamisawa, William R. Brugge et al. · Gut · 2012 · 582 citations · Full text

Medicine, Internal Medicine, Pathology +16

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

Ulrich‐Frank Pape, Aurel Perren, Bruno Niederle et al. · Neuroendocrinology · 2012 · 462 citations · Full text

Medicine, Oncology, Surgery +17